A CAPA is only as defensible as the evidence behind it. QualityHub SVP Rebecca Fuller explains why Verification of Effectiveness planning should begin with the
Implementing a risk-based CAPA approach requires more than adopting a new decision tree, as demonstrated by QualityHub Senior Consultant Aryssa Wernle’s experience implementing MDIC’s “Make
This QualityHub Expert White Paper examines the regulatory foundations, operational principles, and implementation practices associated with effective CAPA systems within the medical device industry. Particular
As the FDA’s QMSR places greater emphasis on risk-based decision-making, medical device manufacturers are expected to align CAPA investigations with the potential impact on product
Early FDA inspection data under the new QMSR framework points to persistent weaknesses in how companies manage risk, oversee suppliers, investigate complaints, maintain UDI compliance,
An effective CAPA system is critical for MedTech manufacturers to meet FDA and ISO requirements and avoid costly compliance failures. This article outlines five expert
This guideline highlights the importance of CAPA systems in pharmaceutical and medical device manufacturing to ensure regulatory compliance and product safety. It explains how CAPA
QualityHub partnered with a global pharmaceutical and medical device company to transform a reactive CAPA system into a proactive, cross-functional process aligned with FDA expectations.
CAPA deficiencies are the most frequently cited issues in regulatory inspections, highlighting the critical role of a robust, well-documented CAPA system across all areas of